Director Finnerty William J executed a sale of 5,000 shares of Delek US Holdings Inc (NYSE:DK) on March 18, 2026, at $45.50 per share, producing a total transaction value of $227,500. The disposition took place as the company's stock traded close to its 52-week high of $46.80, following a year-over-year gain of 172%.
After the sale was completed, Finnerty William J retains direct ownership of 41,369 shares of Delek US. The transaction was implemented through a pre-arranged 10b5-1 trading plan, indicating the trade followed an established schedule or plan rather than being executed on an ad-hoc basis.
Quarterly results provide context for market activity
In related company disclosures, Delek US reported fourth-quarter 2025 results that delivered a strong adjusted earnings per share (EPS) figure of $2.31. That result stood well above analyst expectations of -$0.07, representing a 3,400% positive surprise. At the same time, the company's reported revenue for the quarter was $2.43 billion, which fell short of the consensus forecast of $2.55 billion, a 4.71% negative surprise.
These mixed results - a substantial EPS beat coupled with a revenue shortfall - have been highlighted in market commentary, and they likely factor into investor assessments of the company's near-term performance and valuation. The EPS outperformance has been a focal point for market participants, even as the top-line miss tempers the overall picture.
Summary and implications
The director sale, executed under a 10b5-1 plan, and the company's quarterly financial disclosures together present a nuanced snapshot of recent insider activity and operating results. The sale occurred while the stock was trading near its annual high and after an outsized one-year rally. The earnings surprise and revenue miss provide dual signals that investors and analysts may weigh as they consider the company's prospects.
- Transaction details: 5,000 shares sold at $45.50 each for $227,500 on March 18, 2026.
- Post-sale holdings: Finnerty William J now directly owns 41,369 shares.
- Execution mechanism: Trade conducted under a pre-arranged 10b5-1 trading plan.
- Quarterly performance: Adjusted EPS $2.31 vs. analyst estimate -$0.07 (3,400% positive surprise); revenue $2.43 billion vs. $2.55 billion expected (4.71% negative surprise).
Note: The information above is drawn from company transaction and earnings disclosures. Where details are limited in the underlying disclosures, this report reflects only the facts that were made available.